Literature DB >> 25256921

Substitution-inert trinuclear platinum complexes efficiently condense/aggregate nucleic acids and inhibit enzymatic activity.

Jaroslav Malina1, Nicholas P Farrell, Viktor Brabec.   

Abstract

The trinuclear platinum complexes (TriplatinNC-A [{Pt(NH3 )3 }2 -μ-{trans-Pt(NH3 )2 (NH2 (CH2 )6 NH2 )2 }](6+) , and TriplatinNC [{trans-Pt(NH3 )2 (NH2 (CH2 )6 NH3 (+) )}2 -μ-{trans-Pt(NH3 )2 (NH2 (CH2 )6 NH2 )2 }](8+) ) are biologically active agents that bind to DNA through noncovalent (hydrogen bonding, electrostatic) interactions. Herein, we show that TriplatinNC condenses DNA with a much higher potency than conventional DNA condensing agents. Both complexes induce aggregation of small transfer RNA molecules, and TriplatinNC in particular completely inhibits DNA transcription at lower concentrations than naturally occurring spermine. Topoisomerase I-mediated relaxation of supercoiled DNA was inhibited by TriplatinNC-A and TriplatinNC at concentrations which were 60 times and 250 times lower than that of spermine. The mechanisms for the biological activity of TriplatinNC-A and TriplatinNC may be associated with their ability to condense/aggregate nucleic acids with consequent inhibitory effects on crucial enzymatic activities.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  DNA condensation; nucleic acids; platinum; tRNA; topoisomerase I

Mesh:

Substances:

Year:  2014        PMID: 25256921      PMCID: PMC4311996          DOI: 10.1002/anie.201408012

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  30 in total

1.  Giant DNA molecules exhibit on/off switching of transcriptional activity through conformational transition.

Authors:  Kanta Tsumoto; François Luckel; Kenichi Yoshikawa
Journal:  Biophys Chem       Date:  2003-10-01       Impact factor: 2.352

Review 2.  Sequence-specific interactions of drugs interfering with the topoisomerase-DNA cleavage complex.

Authors:  Manlio Palumbo; Barbara Gatto; Stefano Moro; Claudia Sissi; Giuseppe Zagotto
Journal:  Biochim Biophys Acta       Date:  2002-07-18

3.  Condensation of DNA by multivalent cations: experimental studies of condensation kinetics.

Authors:  S He; P G Arscott; V A Bloomfield
Journal:  Biopolymers       Date:  2000-04-05       Impact factor: 2.505

4.  Human DNA topoisomerase I inhibitory activities of synthetic polyamines: relation to DNA aggregation.

Authors:  A Sukhanova; J Dêvy; M Pluot; J C Bradley; J P Vigneron; J C Jardillier; J M Lehn; I Nabiev
Journal:  Bioorg Med Chem       Date:  2001-05       Impact factor: 3.641

5.  DNA condensation by polyamines: a laser light scattering study of structural effects.

Authors:  V Vijayanathan; T Thomas; A Shirahata; T J Thomas
Journal:  Biochemistry       Date:  2001-11-13       Impact factor: 3.162

6.  Unique cooperative binding interaction observed between a minor groove binding Pt antitumor agent and Hoechst dye 33258.

Authors:  Amanda Harris; Yun Qu; Nicholas Farrell
Journal:  Inorg Chem       Date:  2005-03-07       Impact factor: 5.165

7.  Synthesis and DNA conformational changes of non-covalent polynuclear platinum complexes.

Authors:  Yun Qu; Amanda Harris; Alexander Hegmans; Andrea Petz; Peyman Kabolizadeh; Hana Penazova; Nicholas Farrell
Journal:  J Inorg Biochem       Date:  2004-10       Impact factor: 4.155

Review 8.  Camptothecins: a review of their chemotherapeutic potential.

Authors:  Hulya Ulukan; Peter W Swaan
Journal:  Drugs       Date:  2002       Impact factor: 9.546

9.  The structural mechanism of translocation and helicase activity in T7 RNA polymerase.

Authors:  Y Whitney Yin; Thomas A Steitz
Journal:  Cell       Date:  2004-02-06       Impact factor: 41.582

10.  Human DNA topoisomerase I: An anticancer drug target present in human sarcomas.

Authors:  Landon W Coleman; L Ralph Rohr; Igor B Bronstein; Joseph A Holden
Journal:  Hum Pathol       Date:  2002-06       Impact factor: 3.466

View more
  10 in total

1.  Competitive formation of DNA linkage isomers by a trinuclear platinum complex and the influence of pre-association.

Authors:  Joseph J Moniodis; Donald S Thomas; Murray S Davies; Susan J Berners-Price; Nicholas P Farrell
Journal:  Dalton Trans       Date:  2015-02-28       Impact factor: 4.390

2.  Solution studies on DNA interactions of substitution-inert platinum complexes mediated via the phosphate clamp.

Authors:  Y Qu; R G Kipping; N P Farrell
Journal:  Dalton Trans       Date:  2015-02-28       Impact factor: 4.390

Review 3.  The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.

Authors:  Timothy C Johnstone; Kogularamanan Suntharalingam; Stephen J Lippard
Journal:  Chem Rev       Date:  2016-02-11       Impact factor: 60.622

4.  Substitution-Inert Polynuclear Platinum Complexes That Inhibit the Activity of DNA Polymerase in Triplex-Forming Templates.

Authors:  Jaroslav Malina; Nicholas P Farrell; Viktor Brabec
Journal:  Angew Chem Int Ed Engl       Date:  2018-06-07       Impact factor: 15.336

5.  On the Biology of Werner's Complex.

Authors:  Raphael E F de Paiva; Erica J Peterson; Jaroslav Malina; Mary Zoepfl; J David Hampton; Wyatt E Johnson; Angelica Graminha; Amine Ourahmane; Michael A McVoy; Viktor Brabec; Susan J Berners-Price; Nicholas P Farrell
Journal:  Angew Chem Int Ed Engl       Date:  2021-06-27       Impact factor: 16.823

6.  The phosphate clamp: sequence selective nucleic acid binding profiles and conformational induction of endonuclease inhibition by cationic Triplatin complexes.

Authors:  Andreea Prisecaru; Zara Molphy; Ralph G Kipping; Erica J Peterson; Yun Qu; Andrew Kellett; Nicholas P Farrell
Journal:  Nucleic Acids Res       Date:  2014-11-20       Impact factor: 16.971

7.  Nucleolar targeting by platinum: p53-independent apoptosis follows rRNA inhibition, cell-cycle arrest, and DNA compaction.

Authors:  Erica J Peterson; Vijay R Menon; Laura Gatti; Ralph Kipping; Dilhara Dewasinghe; Paola Perego; Lawrence F Povirk; Nicholas P Farrell
Journal:  Mol Pharm       Date:  2014-12-03       Impact factor: 4.939

8.  C 3-symmetric opioid scaffolds are pH-responsive DNA condensation agents.

Authors:  Natasha McStay; Zara Molphy; Alan Coughlan; Attilio Cafolla; Vickie McKee; Nicholas Gathergood; Andrew Kellett
Journal:  Nucleic Acids Res       Date:  2016-11-28       Impact factor: 16.971

9.  Antiangiogenic platinum through glycan targeting.

Authors:  Erica J Peterson; A Gerard Daniel; Samantha J Katner; Lisa Bohlmann; Chih-Wei Chang; Anna Bezos; Christopher R Parish; Mark von Itzstein; Susan J Berners-Price; Nicholas P Farrell
Journal:  Chem Sci       Date:  2016-08-12       Impact factor: 9.825

10.  Click and Cut: a click chemistry approach to developing oxidative DNA damaging agents.

Authors:  Natasha McStay; Creina Slator; Vandana Singh; Alex Gibney; Fredrik Westerlund; Andrew Kellett
Journal:  Nucleic Acids Res       Date:  2021-10-11       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.